文献速递食管与纵隔外科

剑突下入路与正中胸骨切开术在重症肌无力患者扩大胸腺切除术中实现疾病缓解的等效性

Is a subxiphoid approach equivalent to midline sternotomy for extended thymectomy for achieving disease remission in patients with myasthenia gravis?
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

本文为心脏外科最佳证据专题,通过结构化方案检索106篇文献,纳入5项研究共803例重症肌无力(MG)患者,比较剑突下入路与正中胸骨切开术行扩大胸腺切除术的效果。剑突下组手术时间更短、术中出血更少、住院时间更短、术后疼痛评分更低;两组术后MG危象发生率无显著差异,定量MG评分改善率相似。作者认为,尽管需要进一步高质量研究,但鉴于短期术后结局改善且疾病缓解率相似,剑突下入路胸腺切除术可考虑优先于正中胸骨切开术。

要点

  • 剑突下入路组手术时间更短、术中出血更少、住院时间更短、术后疼痛评分更低。
  • 两组术后MG危象发生率无显著差异,定量MG评分改善率相似。
  • 作者认为,尽管需要进一步高质量研究,剑突下入路可考虑优先于正中胸骨切开术。

核心结论

  • 作者认为,尽管需要进一步高质量研究,但鉴于短期术后结局改善且疾病缓解率相似,剑突下入路胸腺切除术可考虑优先于正中胸骨切开术。

研究设计与样本

  • 采用结构化方案检索心脏外科最佳证据专题,共检索到106篇论文,其中5篇为回答临床问题的最佳证据。
  • 5项研究共纳入803例重症肌无力(MG)患者,比较剑突下入路与正中胸骨切开术行胸腺切除术的经验。

主要发现

  • 剑突下入路组手术时间更短、术中出血更少、住院时间更短、术后疼痛评分更低。
  • 两组术后MG危象发生率无显著差异,定量MG评分改善率相似。

临床怎么用

  • 作者认为,剑突下入路胸腺切除术可考虑优先于正中胸骨切开术,因短期术后结局改善且疾病缓解率相似,但需进一步高质量研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'In patients with myasthenia gravis undergoing extended thymectomy, is a subxiphoid approach equivalent to midline sternotomy for achieving disease remission?' Altogether 106 papers were found using the reported search, of which 5 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Five studies of a total of 803 patients with myasthenia gravis (MG) reported their experience with thymectomy by subxiphoid approach versus thymectomy by midline sternotomy. These studies demonstrated shorter operation duration, reduced intraoperative blood loss, reduced hospital length of stay and lower postoperative pain scores in the subxiphoid group. There was no significant difference in rates of postoperative MG crisis between the 2 groups, and similar rates of improvement in quantitative myasthenia gravis scores. We conclude that while further high-quality research is required, thymectomy by subxiphoid approach for MG may be considered in preference to midline sternotomy due to improved short-term postoperative outcomes and similar disease remission rates.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Zhu A, Kemp U. Is a subxiphoid approach equivalent to midline sternotomy for extended thymectomy for achieving disease remission in patients with myasthenia gravis? Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 38085242. doi:10.1093/icvts/ivad202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。